|
HRMakers |
<ÇìµåÇåÆÃ>¿Ü±¹°è ÀÇ·áÀåºñ ȸ»çÀÇ ¸¶ÄÉÆÃÃÑ°ý Â÷ºÎÀå±Þ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
01.24 |
|
|
ÄܹÙÅØÄÚ¸®¾Æ À¯ÇÑȸ»ç |
[¿Ü±¹°è ÀÇ·á±â±â] Sales supervisor - CCC
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
09.20 |
|
|
(ÁÖ)¿¡ÀÌÁ§ÄÚ¸®¾Æ |
[Á¦¾à,¹ÙÀÌ¿À]°³¹ß¸¶ÄÉÆà °æ·ÂÁ÷ ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇìµåÇåÅÍ |
9³â¡è |
ä¿ë½Ã |
10.20 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Principal Regulatory Affairs Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - Sr CAS Opp
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
SSU |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
±¹Á¦¹é½Å¿¬±¸¼Ò |
Research Assistant (PER) ¸ðÁý
¼¿ï °ü¾Ç±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
7³â¡è |
ä¿ë½Ã |
07.04 |
|
|
(ÁÖ) ³Ø½ºÆ®¼¿·º¼Ç |
Regulatory (RA) Team Leader (Non ¾à»ç )
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
7³â¡è |
ä¿ë½Ã |
12.03 |
|
|
(ÁÖ)½æÅØ |
(ÁÖ)½æÅØ ÀÇ·á±â±â (³»½Ã°æ, º¹°°æ) ¿µ¾÷ °æ·ÂÁ÷
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
7³â¡è |
ä¿ë½Ã |
04.29 |
|
|
±¹Á¦¹é½Å¿¬±¸¼Ò |
Associate Research Scientist (PER) ¸ðÁý
¼¿ï °ü¾Ç±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
7³â¡è |
ä¿ë½Ã |
07.04 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA II (Regional Lead Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
03.29 |
|
|
Ç»ÃÄ¿þÀÌ |
ÀÇ·á±â±â ¿µ¾÷ ´ã´çÀÚ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
7³â¡è |
ä¿ë½Ã |
05.26 |
|
|
½Ã¹ÍÄÚ¸®¾Æ |
[½Ã¹ÍÄÚ¸®¾Æ] Associate Clinical Operations Manager
¼¿ï °³²±¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
»ó½Ãä¿ë |
09.14 |
|
|
(ÁÖ) ³Ø½ºÆ®¼¿·º¼Ç |
E-health Technology Infrastructure Leader
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÇÁ·Î±×·¡¸Ó(À¥,ÀÀ¿ë,½Ã½ºÅÛ) |
7³â¡è |
ä¿ë½Ã |
11.03 |
|
|
(ÁÖ)Ƽ¾ÆÀ̸޵ðÄ®½Ã½ºÅÛÁî |
¢ßƼ¾ÆÀ̸޵ðÄ®½Ã½ºÅÛÁî À繫ȸ°è °æ·Â»ç¿ø ä¿ë°ø°í
¼¿ï ±¸·Î±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
6³â¡è |
»ó½Ãä¿ë |
10.14 |
|
|
(ÁÖ)µð¾ËÁª |
¿¬±¸¼Ò ½Ã½ºÅÛ°ËÁõÆÀ °æ·Â»ç¿ø ¸ðÁý
°æ±â ±¤¸í½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
6³â¡è |
ä¿ë½Ã |
08.21 |
|